496 related articles for article (PubMed ID: 15597149)
1. Comparison of anti-arthritic properties of leflunomide with methotrexate and FK506: effect on T cell activation-induced inflammatory cytokine production in vitro and rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Oct; 53(10):544-50. PubMed ID: 15597149
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
3. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
Magari K; Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
[TBL] [Abstract][Full Text] [Related]
5. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells.
Staruch MJ; Camacho R; Dumont FJ
Cell Immunol; 1998 Dec; 190(2):121-31. PubMed ID: 9878113
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.
Gerards AH; de Lathouder S; de Groot ER; Dijkmans BA; Aarden LA
Rheumatology (Oxford); 2003 Oct; 42(10):1189-96. PubMed ID: 12777636
[TBL] [Abstract][Full Text] [Related]
7. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level.
Andersson J; Nagy S; Groth CG; Andersson U
Immunology; 1992 Jan; 75(1):136-42. PubMed ID: 1371491
[TBL] [Abstract][Full Text] [Related]
8. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
Magari K; Nishigaki F; Sasakawa T; Ogawa T; Miyata S; Ohkubo Y; Mutoh S; Goto T
Inflamm Res; 2003 Dec; 52(12):524-9. PubMed ID: 14991082
[TBL] [Abstract][Full Text] [Related]
9. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
[TBL] [Abstract][Full Text] [Related]
10. FK506 attenuates developing and established joint inflammation and suppresses interleukin 6 and nitric oxide expression in bacterial cell wall induced polyarthritis.
Fuseler JW; Hearth-Holmes M; Grisham MB; Kang D; Laroux FS; Wolf RE
J Rheumatol; 2000 Jan; 27(1):190-9. PubMed ID: 10648038
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis.
Wong PK; Quinn JM; Sims NA; van Nieuwenhuijze A; Campbell IK; Wicks IP
Arthritis Rheum; 2006 Jan; 54(1):158-68. PubMed ID: 16385511
[TBL] [Abstract][Full Text] [Related]
12. FK506 inhibits prostaglandin E2 production from synovial cells by suppressing peripheral blood mononuclear cells.
Sasakawa T; Sasakawa Y; Ohkubo Y; Mutoh S
Int Immunopharmacol; 2005 Jul; 5(7-8):1291-7. PubMed ID: 15914333
[TBL] [Abstract][Full Text] [Related]
13. Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro.
Sakuma S; Kato Y; Nishigaki F; Magari K; Miyata S; Ohkubo Y; Goto T
Int Immunopharmacol; 2001 Apr; 1(4):749-57. PubMed ID: 11357886
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
Ochaion A; Bar-Yehuda S; Cohn S; Del Valle L; Perez-Liz G; Madi L; Barer F; Farbstein M; Fishman-Furman S; Reitblat T; Reitblat A; Amital H; Levi Y; Molad Y; Mader R; Tishler M; Langevitz P; Zabutti A; Fishman P
Arthritis Res Ther; 2006; 8(6):R169. PubMed ID: 17101059
[TBL] [Abstract][Full Text] [Related]
15. FK506 ameliorates spontaneous locomotor activity in collagen-induced arthritis: implication of distinct effect from suppression of inflammation.
Sasakawa T; Sasakawa Y; Ohkubo Y; Mutoh S
Int Immunopharmacol; 2005 Mar; 5(3):503-10. PubMed ID: 15683847
[TBL] [Abstract][Full Text] [Related]
16. FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis.
Sakuma S; Nishigaki F; Magari K; Ogawa T; Miyata S; Ohkubo Y; Goto T
Inflamm Res; 2001 Oct; 50(10):509-14. PubMed ID: 11713905
[TBL] [Abstract][Full Text] [Related]
17. Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells.
Lin SJ; Yan DC; Kuo ML; Cheng PJ; Hsiao SS; Tsai TL
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):586-92. PubMed ID: 16400900
[TBL] [Abstract][Full Text] [Related]
18. Dynamic effects of leflunomide on IL-1, IL-6, and TNF-alpha activity produced from peritoneal macrophages in adjuvant arthritis rats.
Li WD; Ran GX; Teng HL; Lin ZB
Acta Pharmacol Sin; 2002 Aug; 23(8):752-6. PubMed ID: 12147199
[TBL] [Abstract][Full Text] [Related]
19. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis.
Szekanecz Z; Halloran MM; Volin MV; Woods JM; Strieter RM; Kenneth Haines G; Kunkel SL; Burdick MD; Koch AE
Arthritis Rheum; 2000 Jun; 43(6):1266-77. PubMed ID: 10857785
[TBL] [Abstract][Full Text] [Related]
20. Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
Munakata Y; Iwata S; Dobers J; Ishii T; Nori M; Tanaka H; Morimoto C
Arthritis Rheum; 2000 Jul; 43(7):1616-23. PubMed ID: 10902767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
